Cresset Asset Management, LLC Immucell Corp Transaction History
Cresset Asset Management, LLC
- $20.6 Billion
- Q1 2024
A detailed history of Cresset Asset Management, LLC transactions in Immucell Corp stock. As of the latest transaction made, Cresset Asset Management, LLC holds 103,606 shares of ICCC stock, worth $424,784. This represents 0.0% of its overall portfolio holdings.
Number of Shares
103,606
Previous 103,606
-0.0%
Holding current value
$424,784
Previous $527,000
4.17%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ICCC
# of Institutions
26Shares Held
1.02MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA216KShares$886,9400.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny125KShares$512,0440.0% of portfolio
-
Bleichroeder LP New York, NY102KShares$416,5350.17% of portfolio
-
Morgan Stanley New York, NY64.7KShares$265,3350.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX63.4KShares$259,9440.0% of portfolio
About IMMUCELL CORP
- Ticker ICCC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,746,860
- Market Cap $31.8M
- Description
- ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...